Cancer Incidence and Mortality Patterns in Central Asia in 2022 and an Assessment of the Future Burden in 2045
International Journal of Cancer · 16.11.2026
DOI: 10.1002/ijc.70829 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 16.11.2026. Verfasst von Nino Chkhaberidze und 9 weiteren Autor:innen. Beteiligte Einrichtung: International Agency for Research on Cancer (IARC/WHO), Cancer Surveillance Branch, Lyon, France. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Central Asia is undergoing rapid epidemiological transition, yet internationally comparable assessments of cancer profiles in the constituent countries (Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan) remain limited. We aimed to describe patterns of cancer incidence and mortality across the region and to project the future cancer burden through 2045. Cancer incidence and mortality estimates in 2022 were obtained for the five countries from IARC's GLOBOCAN database. Age‐standardised incidence and mortality rates were compared by country, sex and cancer type. The future cancer burden was projected by applying age‐specific cancer rates to population projections, assuming stable rates over time. In 2022, an estimated 92,665 new cancer cases and 56,110 cancer deaths occurred across Central Asia. Kazakhstan had the highest overall incidence and mortality rates, whereas the lowest rates across most major cancer sites were consistently estimated for Tajikistan. Breast cancer was the most common cancer among women, and lung cancer among men. The regional cancer profile was characterised by the coexistence of infection‐related cancers alongside those linked to socioeconomic transition. Assuming stable rates, the annual number of new cancer cases is projected to increase by approximately 65%, reaching 152,000 by 2045, while cancer deaths are projected to increase by 73% to nearly 97,000 deaths. Cancer patterns in Central Asia suggest that regional cancer control planning should be nuanced to reflect each country's profile and resources, balancing prevention of infection‐related cancers with early detection and effective management of common cancers associated with ongoing socioeconomic transitions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- International Agency for Research on Cancer (IARC/WHO), Cancer Surveillance Branch, Lyon, France.
- Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Tashkent, Uzbekistan.
- International Highest School of Medicine, Bishkek, The Kyrgyz Republic.
- National Institute of Public Health of the MoH of the Kyrgyz Republic, Bishkek, The Kyrgyz Republic.
- Department of Fundamental Medicine, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
- National Research Oncology Center, Astana, Kazakhstan.
ORCID-Profile: Nino Chkhaberidze, Ariana Znaor
Zitieren
APA
Chkhaberidze, N., Vignat, J., Djanklich, S., Ten, E., Dushimova, Z., Shatkovskaya, O., Eser, S., Bray, F., Barchuk, A., & Znaor, A. (2026). Cancer Incidence and Mortality Patterns in Central Asia in 2022 and an Assessment of the Future Burden in 2045. International Journal of Cancer. https://doi.org/10.1002/ijc.70829
Vancouver
Chkhaberidze N, Vignat J, Djanklich S, Ten E, Dushimova Z, Shatkovskaya O, et al. Cancer Incidence and Mortality Patterns in Central Asia in 2022 and an Assessment of the Future Burden in 2045. International Journal of Cancer. 2026. doi:10.1002/ijc.70829
BibTeX
@article{Chkhaberidze2026,
author = {Chkhaberidze, Nino and Vignat, Jerome and Djanklich, Sayde and Ten, Elena and Dushimova, Zaure and Shatkovskaya, Oxana and Eser, Sultan and Bray, Freddie and Barchuk, Anton and Znaor, Ariana},
title = {Cancer Incidence and Mortality Patterns in Central Asia in 2022 and an Assessment of the Future Burden in 2045},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70829}
}
EUVIMED